MS Living Well: Key Info from Multiple Sclerosis Experts

Barry Singer, MD

Barry Singer, MD, Director of The MS Center for Innovations in Care at Missouri Baptist Medical Center, interviews global expert guests about the latest treatments, innovations and tips for people living with multiple sclerosis.

  1. 21 lug

    Caregiving in MS

    When multiple sclerosis enters a family, it doesn't just change the life of the person diagnosed. It reshapes the daily routines, roles, and futures of the people who love them. A spouse steps into new responsibilities, a child learns to help in ways their peers never will, and an entire household begins to adapt. These changes occur quietly, and often without recognition. Caregiving is one of the most essential pillars of the MS journey, and also one of the most invisible. This episode explores the caregiver experience from the inside out. We discuss why the uncertainty of MS can be one of the hardest parts of caregiving, how stepping into a care partner role can unexpectedly foster maturity, closeness, and personal growth, and why a caregiver's own well-being is inseparable from that of the person they support. The conversation also dives into practical tools for building resilience including Acceptance and Commitment Therapy, the READY for MS program, and the everyday strategies one husband relies on to stay connected to his wife as they navigate life with MS together. Jameson Holloman MD, neurologist at The MS Center for Innovations in Care, interviews: Kenneth Pakenham PhD, Emeritus Professor of Clinical and Health Psychology at the University of Queensland who pioneered the use of Acceptance and Commitment Therapy in chronic illness and developed the READY for MS resilience program. Dan Shaul, care partner to his wife, Kim, who lives with MS. An Air Force veteran and former Missouri state representative, he serves on the board of MS Bright Spots of Hope in St. Louis.

    Caregiving in MS
  2. 12 mag

    Handling MS: Word-Finding and Memory Strategies

    Cognitive changes are a common part of living with multiple sclerosis, but they can be confusing and frustrating. Many people feel like their memory is slipping, when in reality,  the challenge is often with accessing information—especially in the moment. Forgetting why you walked into a room or struggling to find the right word in conversation are very real experiences in MS, and they're more about how the brain processes and retrieves information than a loss of intelligence or knowledge. New insights are helping us better understand why this happens, including the role of inflammation and how today's treatments may be helping keep cognition more stable over time. In this episode, Dr. James Sumowski breaks down what's happening in the brain, including why word-finding problems are so common and what "working memory" really means in everyday life. Speech-language pathologist Dr. Marissa Barrera then shares practical, easy-to-use strategies to support memory and communication from simple ways to make information more memorable, to talking around a missing word, and creating routines that reduce mental overload. Together, they offer both clarity and actionable tools to help you think more clearly, communicate more confidently, and navigate cognitive challenges day to day. Barry Singer, MD, Director of The MS Center for Innovations in Care, interviews: James F. Sumowski, PhD, Associate Professor of Neurology at the Icahn School of Medicine, Mount Sinai, New York Marissa Barrera, PhD, MSCS, CCC-SLP, Assistant Dean of Health Sciences, Katz School of Science and Health, Yeshiva University, New York

    Handling MS: Word-Finding and Memory Strategies
  3. 18/11/2025

    The Science of MS Supplements

    Many people living with multiple sclerosis are interested in whether vitamins, supplements, or nutrition can play a supportive role in long-term brain and immune health. Two areas that have received growing research attention are alpha-linolenic acid, a plant-based omega-3 fatty acid found in foods like flaxseed and walnuts, and vitamin D, a hormone-like nutrient involved in immune regulation that is often low in people with MS. With so much information online, it can be difficult to know what is truly supported by research versus what is based on personal stories or assumption. New studies are helping us understand these topics more clearly. We explore new insights from large-scale cohort studies and randomized clinical trials assessing the potential role of alpha-linolenic acid and high-dose vitamin D supplementation in early MS. Biomarker-based findings show an association between higher alpha-linolenic acid levels and reduced relapse risk and disability progression over long-term follow-up. The D-Lay MS trial demonstrated a reduction in disease activity in people living with MS receiving high-dose vitamin D early in their condition. Jamie Holloman MD, neurologist at The MS Center for Innovations in Care, interviews: Marianna Cortese MD PhD, Senior Research Scientist, Department of Nutrition at Harvard T.H. Chan School of Public Health Professor Éric Thouvenot, Head of the Neurology Department, Nîmes University Hospital, France

    The Science of MS Supplements
  4. 14/10/2025

    Reengineering Hope: CAR-T Therapy for Multiple Sclerosis

    CAR-T therapy, short for chimeric antigen receptor T-cell therapy, is already transforming treatment for blood cancers like lymphoma and leukemia and is now being tested in early trials for multiple sclerosis. In this approach, a person's own T cells (or sometimes donor T cells) are collected and reengineered in the lab with a special "chimeric" receptor on their surface. Once infused back into the body, these "designer" T cells can specifically hunt down B cells, including those hiding in the brain and spinal cord that may drive progressive MS. This is a key difference since current B-cell depleting antibody treatments don't reach effectively into the central nervous system. Like any powerful therapy, CAR-T is not without risks. Side effects can include serious infections, cytokine release syndrome (fever, chills, body aches), and even neurological symptoms like confusion or seizures. Still, the early results in MS patients are remarkable, bringing fresh hope for those with progressive disease. Beyond MS, CAR-T is being explored across autoimmune neurological diseases from myasthenia gravis to stiff person syndrome, opening a promising new frontier in care. Barry Singer MD, Director of the MS Center for Innovations in Care, interviews: Jeffrey Dunn MD, Clinical Professor and Chief of Neuroimmunology in the Department of Neurology & Neurological Sciences at Stanford University Amanda Piquet MD, Professor of Neurology and Céline Dion Foundation Endowed Chair at the University of Colorado Anschutz School of Medicine

    Reengineering Hope: CAR-T Therapy for Multiple Sclerosis
  5. 09/09/2025

    Repairing MS: The Quest to Rebuild Myelin

    The quest to repair the damage caused by multiple sclerosis is gaining momentum, with scientists working to restore lost function and slow progression by rebuilding myelin—the protective coating of nerve cells. Within the brain and spinal cord, immature myelin-making cells called OPCs hold promise, but need the right signals to mature into oligodendrocytes and repair MS lesions. Researchers are also studying the role of microglia, the immune cells that clear debris but can turn destructive, with drugs like BTK inhibitors potentially tilting them toward repair. Early attempts at remyelination drugs such as opicinumab and elezanumab showed promise in animals but ultimately failed in human trials, underscoring the challenge. Still, reasons for optimism are emerging: clemastine, a common antihistamine, showed signs of remyelination in optic neuritis, while PIPE-307—a compound inspired by green mamba snake venom—is in Phase 2 trials. Even novel approaches like gold nanoparticles are being studied to boost oligodendrocyte energy and repair capacity. The path is complex, but progress is accelerating—bringing remyelination therapies closer to becoming a real option for people living with MS. Barry Singer MD, Director of The MS Center for Innovations in Care, interviews: Veronique Miron PhD, MS Research Chair at St. Michael's Hospital and Professor of Immunology at The University of Toronto Robert Glanzman MD, Board-certified neurologist and Chief Medical Officer of Find Therapeutics

    Repairing MS: The Quest to Rebuild Myelin

Descrizione

Barry Singer, MD, Director of The MS Center for Innovations in Care at Missouri Baptist Medical Center, interviews global expert guests about the latest treatments, innovations and tips for people living with multiple sclerosis.

Potrebbero piacerti anche…